Egypt Gynecomastia Treatment Market Size & Outlook, 2026-2034
Egypt Gynecomastia Treatment Market Insights
- Reed Intelligence analysis indicates that the Egypt Gynecomastia Treatment Market size, valued at USD 18.14 Million in 2025, is expected to expand to USD 34.11 Million by 2034.
- The Egypt market is forecasted to expand at a CAGR of 7.31% spanning 2026–2034.
- Surgical held the leading position among Treatment Type segments in 2025, based on market size.
- Non-Surgical is projected to post the fastest growth rate, sustaining its position as the most attractive Treatment Type segment during the forecast horizon.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Egypt contributed 0.78% to the global Gynecomastia Treatment Market size in 2025.
- By 2034, United States is forecasted to remain the largest global market for Gynecomastia Treatment Market.
- In Middle East and Africa, United Arab Emirates is projected to capture the leading share of market size by 2034.
- Among Middle East and Africa markets, United Arab Emirates is expected to post the fastest growth, reaching USD 150.25 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 18.14 Million |
| Market Size In 2034 | USD 34.11 Million |
| Largest segment | Surgical |
| Units | Revenue in USD Million |
| CAGR | 7.31% (2026-2034) |
| Segmnetation Covered | |
| Treatment Type |
|
| End-Use |
|
| Patient Age Group |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Egypt Gynecomastia Treatment Market Treatment Type 2026-2034 (USD Million)
| Treatment Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical | XX.x | XX.x | XX.x | 10 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Non-Surgical | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Egypt Gynecomastia Treatment Market End-Use 2026-2034 (USD Million)
| End-Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | XX.x | XX.x | XX.x | 8.45 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cosmetic Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ambulatory Surgical Centers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Egypt Gynecomastia Treatment Market Patient Age Group 2026-2034 (USD Million)
| Patient Age Group | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adolescents | XX.x | XX.x | XX.x | 9.95 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Adults | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Elderly | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
